Pre-treatment Levels of Circulating Free IGF-1 Identify NSCLC Patients Who Derive Clinical Benefit From Figitumumab
- Type
- Retraction
- Notice date
- 12/4/2012 0:00
- Journal
- British Journal of Cancer
- Publisher
- Nature Publishing Group
- Notice DOI
- 10.1038/bjc.2012.497
- Original paper DOI
- 10.1038/sj.bjc.6605972